NCT01127880View on ClinicalTrials.gov

Role of Antibiotics to Reduce Infectious Complications in Tube Thoracotomy Management of Traumatic Hemopneumothorax

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
HemopneumothoraxPneumothorax
Interventions
DRUG

Ancef or Clindamycin

1 gm of Ancef or 300 mg Clindamycin for those who are penicillin allergic

DRUG

Placebo

.9% Normal Saline as a placebo

Trial Locations (1)

18015

St. Luke's Hospital and Health Network, Bethlehem

All Listed Sponsors
lead

St. Luke's Hospital, Pennsylvania

OTHER

NCT01127880 - Role of Antibiotics to Reduce Infectious Complications in Tube Thoracotomy Management of Traumatic Hemopneumothorax | Biotech Hunter | Biotech Hunter